Gary Anthony Pestano sold $596 of BDSX
Chief Development Officer at BIODESIX INC. 427 shares at an average of $1.40, traded Nov 11, 2024, filed Nov 13, 2024.
Score components
- +15RoleOfficer
- 0Trade size$596 at market
- 0Share of holdings soldSold 0.3% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -4.3%, 3m -32.9%, 6m -84.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000905148-24-003058, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 8, 2024 | MOption exercise Common Stock | +1,378 | - | - | 127,454 | Nov 13, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stock | -220 | $1.39 | $306 | 127,234 | Nov 13, 2024 |
| Nov 12, 2024 | SOpen-market sale Common Stock | -207 | $1.40 | $290 | 127,027 | Nov 13, 2024 |
| Nov 8, 2024 | MOption exercise Restricted Stock Unitsderivative | -1,378 | $0.00 | $0 | 6,891 | Nov 13, 2024 |
Related signals
Other insiders at BIODESIX INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | BIODESIX INC | Kieran O'Kane Chief Commercial Officer | $6,835 535 shares | -5% | |
| 15Weak | BIODESIX INC | Gary Anthony Pestano Chief Development Officer | $7,103 556 shares | -5% | |
| 25Weak | BIODESIX INC | Scott Hutton President & CEO | $19k 1,490 shares | -3% | |
| 22Weak | BIODESIX INC | Robin Harper Cowie CFO, Sec'y & Treasurer | $6,835 535 shares | -3% | |
| 20Weak | BIODESIX INC | Chris Vazquez Chief Accounting Officer | $2,696 211 shares | -12% | |
| 31Weak | BIODESIX INC | Scott Hutton President & CEO | $36k 3,559 shares | -7% | |
| 15Weak | BIODESIX INC | Gary Anthony Pestano Chief Development Officer | $5,445 540 shares | -5% | |
| 15Weak | BIODESIX INC | Kieran O'Kane Chief Commercial Officer | $5,889 584 shares | -6% | |
| 15Weak | BIODESIX INC | Chris Vazquez Chief Accounting Officer | $1,018 101 shares | -8% | |
| 22Weak | BIODESIX INC | Robin Harper Cowie CFO, Sec'y & Treasurer | $9,489 941 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.